References
1a
Sack RL.
Lewy AJ.
Parrot K.
Singer CM.
McArthur AJ.
Blood ML.
Bauer VK.
Eur. J. Med. Chem.
1995,
30:
661
1b
Dollins AB.
Zhdanova IV.
Wurtman RJ.
Lynch HJ.
Deng MH.
Proc. Natl. Acad. Sci. U.S.A.
1994,
91:
1824
1c
Zhdanova IV.
Wurtman RJ.
Lynch HJ.
Ives JR.
Dollins AB.
Morabito C.
Matheson JK.
Schomer DL.
Clin. Pharmacol. Ther.
1995,
57:
552
2a
Petrie K.
Conaglen JV.
Thompson L.
Chamberlain K.
Br. Med. J.
1989,
298:
705
2b
Arendt J.
Aldhous M.
Marks V.
Annu. Rev. Chronopharmacol.
1986,
3:
49
3
Odani A.
Ferini-Strambi L.
Zucconi M.
Stankof B.
Frachini F.
Smirne S.
Neuro Report
1994,
6:
132
4a
Reiter RJ.
Menendez-Pelaez A.
Poeggeler B.
Tan D.-X.
Pablos MI.
Acuna-Castroviejo D.
Advances in Pineal Research
Moller M.
Pevet P.
John Libbey and Co.;
London:
1994.
p.403
4b
Marshall K.-A.
Reiter RJ.
Poeggeler B.
Aruoma OI.
Halliwell B.
Free Radical Biol. Med.
1996,
21:
307
4c
Cuzzocrea S.
Zingarelli B.
Gilad E.
Hake P.
Salzman AL.
Szabo CJ.
Pineal Res.
1997,
23:
106
4d
Reiter RJ.
Tang L.
Garcia JJ.
Munos-Hoyos A.
Life Sci.
1997,
62:
853
4e
Antunes F.
Barclay LRC.
Ingold KU.
King M.
Norris JQ.
Scaiano JC.
Xi P.
Free Radical Biol. Med.
1999,
26:
117
5
Zhang H.
Squadrito GL.
Uppu R.
Pryor WA.
Chem. Res. Toxicol.
1999,
12:
526
6
Turjanski AG.
Rosenstein RE.
Estrin DA.
J. Med. Chem.
1998,
41:
3684
7 Metabolites of melatonin formed either in the peripheral or CNS are potent inhibitors of the calcium-dependent release of dopamine from retina. K2, (IC50: 10 nM) which is formed in the CNS are potent activators of melatonin receptor sites in retina.
8
Hirata F.
Hayaishi O.
Tokuyama T.
Senboh S.
J. Biol. Chem.
1974,
249:
1311
9
Nakagawa M.
Okajima H.
Hino T.
J. Am. Chem. Soc.
1977,
99:
4424
10
Kondo Y.
Kojima S.
Sakamoto T.
J. Org. Chem.
1997,
62:
6507
11 Reaction of 2 with γ-butyrolactone gave the required keto-alcohol product.
12a
Sonogashira K.
Tohda Y.
Hagihara N.
Tetrahedron Lett.
1975,
4467
12b
Sonogashira K. In Comprehensive Organic Synthesis
Vol. 3:
Trost BM.
Fleming L.
Pergamon Press;
New York:
1991.
Chap. 2.4.
These compounds have been prepared form Weinreb amides, see:
13a
Gomtsyan A.
Org. Lett.
2000,
2:
11
13b
Gomtsyan A.
Koenig RJ.
Lee C.-H.
J. Org. Chem.
2001,
66:
3613
14 To a solution of tert-butyl (4-methoxyphenyl) carbamate (10.0 g, 44.82 mmol) in dry THF (112 mL) under N2 at
-78 °C, was added a solution of tert-butyllithium in pentane (68.56 mL, 116.53 mmol). After 15 min the solution was warmed to -20 °C and kept at that temperature for 2.5 h whereupon a solution of 1,2-iodoethane (18.95 g, 67.23 mmol) in dry THF (40 mL) was added. The reaction mixture was stirred at ambient temperature overnight. After quenching with sat. aq Na2S2O3 solution (170 mL), the reaction mixture was extracted with Et2O (3 × 270 mL). The organic phase was washed with brine (160 mL), dried over Na2SO4, filtered and concentrated. Flash chromatography (hexane/Et2O, 10:1) afforded 3 (9.97 g. 63.74%) as colorless prisms, mp 49-51 °C. IR (KBr): 3346 (s), 2978 (m), 1700 (s), 1515 (s), 1163 (s)cm-1; 1H NMR (200 MHz, CDCl3): δ = 7.75 (d, J = 9.1 Hz, 1 H), 7.23 (d, J = 2.9 Hz), 6.85 (dd, J = 2.9, 9.0 Hz), 6.55 (br, 1 H), 3.76 (s, 3 H), 1.53 (s, 9 H); 13C NMR (90 MHz, CDCl3): δ = 155.9, 153.0, 132.3, 123.6, 114.8, 80.7, 55.6, 28.3; MS: m/z = 349 [M+].
15 To a solution of 3 (1.75 g, 5 mmol), PdCl2[PPh3]2 (140.3 mg, 0.2 mmol), CuI (85 mg, 0.45 mmol), in dry Et3N (9.12 mL) at r.t. under N2 atmosphere, was slowly added N-acetyl propargylamine (0.65 g, 6.65 mmol) (30 min). The reaction mixture was stirred at r.t. for 1 h and then partitioned between Et2O (25 mL) and brine (7 mL). The organic layer was dried over MgSO4, filtered and evaporated to give 176 mg. Flash chromatography (ethyl acetate/hexane, 2:1) afforded 4, tert-butyl(2-[3′-N-acetylaminopropargyl]-4-methoxy phenyl) carbamate, (122 mg, 76.7%) as white crystals, mp 114-118 °C. IR (KBr): 3328 (s), 1698 (s), 1652 (s), 1525 (s), 1292 (s), 1163 (s)cm-1; 1H NMR (200 MHz, CDCl3): δ = 7.97 (d, J = 9.89 Hz, 1 H), 6.96 (br, 1 H), 6.96-6.83 (mt, 2 H), 6.05 (br, 1 H), 4.33 (d, J = 5.11 Hz, 2 H), 3.75 (s, 3 H), 2.05 (s, 3 H), 1.53 (s, 9 H); 13C NMR (90 MHz, CDCl3): δ = 199.91, 154.32, 152.69, 133.13, 119.68, 116.28, 115.83, 111.91, 91.42, 80.55, 78.50, 55.36, 29.91, 28.20, 22.79; HRMS (ES, Na): m/z = 341.1473 ([M + Na]+; calcd for C17H22N2O4Na: 341.3564).
16 Mercuric sulfate (0.36 g, 1.13 mmol), distd H2O (2.75 mL), formic acid (19.25 mL) and DCM (11 mL) were magnetically stirred in a 100 mL round bottom flask until the mixture had dissolved. To this solution, 4 (0.36 g, 1.12 mmol) was added over 0.5 h and stirring at 42 °C was continued for 4 h. Solid NaHCO3 was added to adjust solution to pH 7-8 and the reaction mixture was freeze dried followed by extraction with EtOAc (3 × 50 mL). The organic phase was washed with H2O (100 mL), brine (100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (EtOAc-MeOH, 30:1) afforded K
1
(0.165 g, 62%) as fine white needles, mp 142-144 °C and K
2
(0.0421 g, 14.1%), mp K
1
IR (KBr): 3331 (m), 1687 (s), 1671 (s), 1649 (s), 1540 (s), 1195 (s)cm-1; 1H NMR (200 MHz, CDCl3): δ = 11.15 (br, 1 H), 8.53 (d, J = 9.16 Hz, 1 H), 8.31 (d, J = 1.65 Hz, 1 H), 7.26 (d, J = 2.75 Hz, 1 H), 7.03 (dd, J = 2.75, 9.16 Hz), 6.99 (dd, J = 2.75, 9.16 Hz), 6.2 (br, 1 H), 3.72 (s, 3 H), 3.6-3.4 (m, 2 H), 3.2-3.1 (m, 2 H), 1.86 (s, 3 H); 13C NMR (90 MHz, CDCl3): δ = 203.20, 170.242, 159.35, 154.83, 133.10, 123.07, 120.66, 118.07, 115.46, 55.64, 39.64, 34.42, 23.19; HRMS (ES, Na): m/z = 287.1004 ([M + Na]+; calcd for C13H16N2O4Na: 287.2662).
17 Mercuric sulfate (0.36 g, 1.13 mmol), 10% H2SO4 (25 mL) and CH3OH (10 mL) were magnetically stirred in a 100 mL round bottom flask until the mixture had dissolved. To this solution, 4 (0.36 g, 1.12 mmol) was added over 0.5 h and stirring at 42 °C was continued for 5 h. Solid NaHCO3 was added to adjust solution to pH 7-8 and the reaction mixture was freeze dried followed by extraction with EtOAc (3 × 50 mL). The organic phase was washed with H2O (100 mL), brine (100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (EtOAc-MeOH, 30:1) afforded K
2
(0.154 g, 58%) as yellow powder, mp 86-88 °C. IR (KBr): 3446 (s), 3339 (s), 2937 (s), 1731 (s), 1651 (s), 1557 (s), 1237 (s)cm-1; 1H NMR (200 MHz, CDCl3): δ = 7.13 (d, J = 2.93 Hz, 1 H), 6.99 (dd, J = 2.93, 8.9 Hz, 1 H), 6.95 (dd, J = 2.93, 8.9 Hz, 1 H), 6.3 (br, 1 H), 5.8-5.0 (br, 2 H); 13C NMR (90 MHz, CDCl3): δ = 200.87, 170.10, 150.14, 145.04, 123.94, 118.83, 117.32, 112.95, 55.91, 38.72, 34.49, 23.30; HRMS (ES, Na): m/z = 259.1054 ([M + Na]+; calcd for C12H16N2O3Na: 259.2623).